◆英語タイトル:Cardiatis SA - Product Pipeline Analysis, 2017 Update
◆商品コード:DATA8010045
◆発行会社(調査会社):
GlobalData
◆発行日:2017年12月27日
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ベルギー
◆産業分野:医療機器
◆販売価格オプション(消費税別)
※
販売価格オプションの説明はこちらで、
ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※
GlobalData社の概要はこちらでご確認いただけます。
【レポートの概要】
Summary
Cardiatis SA (Cardiatis) is a medical device company that develops a multilayer technology platform for endovascular aneurysm. The company offers a three dimensional multilayer braided stent system for endovascular aneurysm repair. Its multilayer flow modulator include aortic, peripheral, bifurcated, and intracranial devices. Cardiatis product is applied across aneurysms in cerebral, aortic, or peripheral locations to prevent death from aneurysm rupture. The company also develops simulation and analysis tools such as ansys, comsol, and mimics that allow virtual simulation. It distributes its products across Argentina, Brazil, Colombia, India, Israel, Singapore, South Korea, Sri Lanka, Thailand, and others. Cardiatis is headquartered in Isnes, Belgium.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Cardiatis SA
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
Cardiatis SA Company Overview 4
Cardiatis SA Company Snapshot 4
Cardiatis SA Pipeline Products and Ongoing Clinical Trials Overview 4
Cardiatis SA – Pipeline Analysis Overview 7
Cardiatis SA – Key Facts 7
Cardiatis SA – Major Products and Services 8
Cardiatis SA Pipeline Products by Development Stage 9
Cardiatis SA Ongoing Clinical Trials by Trial Status 11
Cardiatis SA Pipeline Products Overview 13
Bifurcated Multilayer Flow Modulator Kit 13
Bifurcated Multilayer Flow Modulator Kit Product Overview 13
Bifurcated Multilayer Flow Modulator Kit Clinical Trial 14
Cardiatis C5 15
Cardiatis C5 Product Overview 15
Cardiatis FluidSmart 3D Stent 16
Cardiatis FluidSmart 3D Stent Product Overview 16
Intracranial Multilayer Flow Modulator 17
Intracranial Multilayer Flow Modulator Product Overview 17
Cardiatis SA – Key Competitors 18
Cardiatis SA – Locations And Subsidiaries 19
Head Office 19
Recent Developments 20
Cardiatis SA, Recent Developments 20
Nov 17, 2014: VEITH Symposium Presentations Highlight Use of Cardiatis Multilayer Flow Modulator Technology as Endovascular Disease Modifying Treatment for Thoracoabdominal Aortic Aneurysms 20
Oct 14, 2014: Cardiatis Targets Crawford V Thoracoabdominal Aortic Aneurysms with Cardiatis C5 Second Generation Multilayer Flow Modulating Endograft 20
Jun 09, 2009: Cardiatis Receives European Approval For Multilayer Aneurysm Repair System 21
Oct 30, 2007: Successful Exclusion Of A Renal Artery Aneurysm With Cardiatis FluidSmart 3D Multilayer Stent 21
Sep 25, 2007: First Popliteal Aneurysm Patient Successfully Treated With Cardiatis FluidSmart 3D Multilayer Stent System 21
Appendix 22
Methodology 22
About GlobalData 24
Contact Us 24
Disclaimer 25
List of Tables
Cardiatis SA Pipeline Products and Ongoing Clinical Trials Overview 4
Cardiatis SA Pipeline Products by Equipment Type 5
Cardiatis SA Pipeline Products by Indication 6
Cardiatis SA Ongoing Clinical Trials by Trial Status 6
Cardiatis SA, Key Facts 7
Cardiatis SA, Major Products and Services 8
Cardiatis SA Number of Pipeline Products by Development Stage 9
Cardiatis SA Pipeline Products Summary by Development Stage 10
Cardiatis SA Ongoing Clinical Trials by Trial Status 11
Cardiatis SA Ongoing Clinical Trials Summary 12
Bifurcated Multilayer Flow Modulator Kit - Product Status 13
Bifurcated Multilayer Flow Modulator Kit - Product Description 13
Bifurcated Multilayer Flow Modulator Kit - Evaluation of Safety and Efficacy of the Bifurcated Multilayer Flow Modulator: BMFM 14
Cardiatis C5 - Product Status 15
Cardiatis C5 - Product Description 15
Cardiatis FluidSmart 3D Stent - Product Status 16
Cardiatis FluidSmart 3D Stent - Product Description 16
Intracranial Multilayer Flow Modulator - Product Status 17
Intracranial Multilayer Flow Modulator - Product Description 17
Glossary 23